Jeff Lagasse
The organization also logged strong operating income, which was $156 million for the third quarter, compared to a $75M operating loss last year.
Lawmakers are concerned that CMS' 2024 final Part C and D rule may not adequately address MA plans' increased reliance on AI.
Premier and the American Hospital Association laud a recent Supreme Court decision but say HHS is still acting unlawfully.
The three in five people who were offered and who accessed their online record or patient portal last year was a 50% increase over 2020.
The company cites clinical expertise and service capabilities across the company, boosted by "disciplined execution."
Doctors' Management Services failed to determine the potential risks and vulnerabilities in the breach, HHS says.
A number of factors contributed to the company's financial performance, including the August launch of Cordavis and its MA offerings.
Nostrum admitted it acquired Nitro OS from another manufacturer and continued to market it based on its preexisting FDA approval.
Lack of transparency limits the ability of regulators to monitor prices and of employers and patients to impose market discipline on prices.
Final rule increases payment for certain new renal dialysis drugs and biological products.